γ-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor
Inhibition of human angiogenesis with heparin and hydrocortisone
Quantitative analysis of angiogenesis using confocal laser scanning microscopy
Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes
Control of VEGF expression via hypoxia and MAP kinase signaling
VEGF-C, VEGF-D and VEGFR-3 in tumor angiogenesis, lymphangiogenesis and metastasis
Autocrine and paracrine interactions of FGF2 with endothelial cells
Endothelial cell growth and death in angiogenesis
Vascular targeting agents to VEGFR2
Molecular anatomy of blood vessels
In silico cloning of novel endothelial specific genes
Human methionine aminopeptidase – a novel target associated with inhibition of angiogenesis
Modulation of angiogenesis by ginsenosides
VEGFs, angiopoietins and ephrins
Inhibition of VEGF signal transduction in cancer
Drug based approaches which selectively damage tumour vasculature
Promoting angiogenesis
The clinical future of anti-angiogenic agents
Methionine aminopeptidase-2
Gastric injury activates sequential expression of VEGF, bFGF, Ang2 and Ang1 genes in mucosa bordering necrosis
NSAIDs inhibit endothelial proliferation by interference with cell cycle regulatory proteins
Single local injection of VEGF and angiopoietin-1 DNAs dramatically accelerates gastric ulcer healing and improves quality of scar
Mutations interfere with VEGFR-3 function in primary lymphedema
Effect of prostaglandins and adenosine on angiogenic growth factors in skeletal muscle cells and in endothelial cells
Vascular endothelial growth factor (VEGF) plays a crucial role in the proliferation of endothelial cells
Fabrication of alginate scaffolds containing controlled delivery microspheres of VEGF and bFGF to enhance scaffold vascularization
Interaction of endostatin, an endogenous angiogenesis inhibitor, with heparin
Neoangiogenesis in the injured rat spinal cord
RNA splicing alterations associated with angiogenesis
Expression of vascular endothelial growth factor and study of papillary blood vessels pattern in primary superficial bladder carcinoma
In vitro and in vivo characterization of RGD based protein carriers for tumor vasculature targeting
Identification of novel modulators of angiogenesis using arrayed adenoviral expression libraries
Acidosis prevents endothelial cell apoptosis by Axl activation
Different effect of high and low shear stress on PGDF release by endothelial cells and smooth muscle cell migration
Boron and wound healing
Antitumour effects of tumour necrosis factor are host mediated and vasculature targeted
The density of endoglin immunostained blood vessels is prognostic for survival in prostate cancer
Increased angiogenesis and tumour size in β3-integrin deficient mice is associated with increased VEGF-receptor levels
Identification of specific targets for inhibition of endothelial cell proliferation and differentiation
Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes
Screening of new modulators of angiogenesis from marine sources
Monoclonal anti-idiotypic antibodies targeting VEGF receptors
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo